ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

CBDG THC Farmaceuticals Inc (PK)

0.0427
0.00 (0.00%)
Last Updated: 14:30:28
Delayed by 15 minutes
Share Name Share Symbol Market Type
THC Farmaceuticals Inc (PK) USOTC:CBDG OTCMarkets Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 0.0427 0.0101 0.0399 0.00 14:30:28

EUROPE MARKETS: European Stocks Slump As Banks Decline, Data Disappoint

12/11/2014 10:15pm

Dow Jones News


THC Farmaceuticals (PK) (USOTC:CBDG)
Historical Stock Chart


From May 2019 to May 2024

Click Here for more THC Farmaceuticals (PK) Charts.

By Carla Mozee, MarketWatch OECD foresees slowing growth in Europe

LONDON (MarketWatch) -- European stocks dropped Wednesday, with bank issues lower after some heavyweight financial services agreed to pay a multi-billion dollar fine to settle allegations that traders at the firms helped rig currency markets.

Losses overall accelerated after data underscored weakness in regional economic activity.

Big banking settlement:Five banks have agreed to pay a total of $3.3 billion to U.S., British and Swiss regulators to resolve a long-running investigations into whether the banks engaged in activities within their foreign-exchange units that helped rig spot market prices.

HSBC Holdings PLC, Royal Bank of Scotland Group PLC, UBS AG, Citigroup Inc. and J.P. Morgan Chase & Co. made settlements with British and U.S. authorities. UBS was separately ordered by Switzerland's Finma to pay 134 million Swiss francs ($139 million).

Investors later in the session learned from the European Union's statistics agency that industrial output in the eurozone rose 0.6% in September from August. That figures was just below a rise of 0.7% expected by economists polled by The Wall Street Journal. But the advance didn't reverse the 1.4% drop in August, indicating that third-quarter output will be lower than in the second quarter.

Separately, the Organization for Economic Cooperation and Development said economic growth is set to slow in the eurozone and in the U.K. over the coming months.

Markets: The Stoxx Europe 600 index fell 1.1% to close at 335.09, falling from a five-week closing high reached on Tuesday.

In the banking group, shares of HSBC Holdings PLC (HSBC) dropped 0.3%, RBS (RBS) fell 1%, and UBS AG (UBS) lost 0.1%. Shares of Barclays PLC (BCS) dropped 2.2% as the bank pulled out of late-stage settlement talks with regulators, saying it decided to seek a "more general coordinated settlement."

The pullback in bank shares weighed on the U.K.'s FTSE 100 , which fell 0.3% to 6,611.04. Meanwhile, the British pound fell after the Bank of England cut its forecasts for growth and inflation and signaled it is unlikely to raise interest rates until the second half of next year. The pound (GBPUSD) fell to $1.5817, from $1.5918 late on Tuesday. Read: Pound creeps toward one-year low after action-packed day

France's CAC 40 index gave up 1.5% to 4,179.88 and Germany's DAX 30 index fell 1.7% to 9,210.96.

You're invited: A free evening event focusing on investing opportunities in Europe

Will you be in London on Dec. 3? Then you're invited to our MarketWatch Investing Insights event, "The worse Europe gets, the more you should invest."

Governments are in trouble, reform efforts have stalled, unemployment is climbing. the news from the eurozone is bleak. And investors are fleeing. But that's a mistake: The worse the economic data from Europe get, the more you should be buying. Why? Because actions by the ECB will boost asset prices and the stock market in particular. And, big exporters can grow sales. Lower costs and steady sales translate into higher profits and dividends. Join us for an evening of cocktails and conversation to explore these opportunities.

Our panel will be led by MarketWatch Columnist Matthew Lynn, a renowned financial journalist based in London and the author of "Bust: Greece, the Euro and the Sovereign Debt Crisis." He'll be joined by Mark Hulbert, MarketWatch columnist and editor of the Hulbert Financial Digest. This event is free, but RSVPs are required. It will be held Wednesday evening, Dec. 3, in London. For more information or to RSVP, send an email to marketwatchevent@wsj.com

Subscribe to WSJ: http://online.wsj.com?mod=djnwires


1 Year THC Farmaceuticals (PK) Chart

1 Year THC Farmaceuticals (PK) Chart

1 Month THC Farmaceuticals (PK) Chart

1 Month THC Farmaceuticals (PK) Chart

Your Recent History

Delayed Upgrade Clock